Afectación extrahepática como primera manifestación de la infección por el virus de la hepatitis C

Medicina Clinica

Volumn 111, Issue 17, 1998, Pages 667-669

  Rivera Redondo, Javier ^a,c   García Monforte, Aurelio ^a   Núñez Cortés, Jesús Millán ^b  

^a Servicio de Reumatología   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C; HUMAN; REVIEW;

HEPATITIS C; HUMANS;

EID: 0032556311     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agente of viral non-A non-B hepatitis. Br Med Bull 1990; 46: 423-441.
2. Suárez A, Linares A, San Román FS, Rodrigo L. Utilidad de la determinatión de ALT en la deteccion de casos anti-VHC positivos entre donantes de sangre. Med Clin (Barc) 1993; 101: 38.
3. Prieto M, Olaso V, Verdu C, Córdoba J, Gisbert C, Rayon M et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polimerase chain reaction. Hepatology 1995; 22: 413-417.
4. Follet EAC, Dow BC, McOmish P, Lee Yap P, Hughes W, Mitchell IR et al. HCV confirmatory test of blood donors. Lancet 1991; 338: 1.024.
5. Conry-Cantilena C, Van Raden M, Gibble J, Melpolder J, Obald Shakil A, Viladomiu L et al. Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1.691-1.696.
6. Sacristán B, Castañares MJ, Elena A, Sacristán M, Barcenilla J, García JC et al. Infección por el virus de la hepatitis C. Estudio seroepidermico en población general de La Rioja. Med Clin (Barc) 1996; 107: 331-335.
7. Bruguera M. La hepatitis C, otra plaga. Med Clic (Barc) 1994; 103: 615-616.
8. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sánchez Tapias JM et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1.004.
9. Crespo J, Dueñas C, Sánchez-Antolín G, Fábrega E, Carte B, Pons-Romero F. Infección por el virus de la hepatitis B y C en pacientes con carcinoma hepatocelular. Med Clin (Barc) 1996; 106: 241-245.
10. Crespo J, Casalont F, Carte B, Lozano JL, Fábrega E, Sánchez-Antolín G et al. Recidiva de la hepatitis por el virus de la hepatitis C en los pacientes receptores de trasplante hepático. Med Clin (Barc) 1997; 108: 98-102.
11. Llach J, Rimolas A, Arrollo V, García Valdecasas JC, Grande L, Visa J et al. Trasplante hepático: selección de candidalos y resultados obtenidos en un programa para adultos. Med Clin (Barc) 1991; 96: 41-46.
12. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-385.
13. Navas S, Castillo I, Bartolomé J, Marriot E, Herrero M, Carreño V. Positive and negative hepatitis C virus RNA stands in serum, liver and peripheral mononuclear cells in anti-HCV patients: relation with the liver lesion. J Hepatol 1994; 21: 182-186.
14. De Vila S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Conrachiulo V et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 5: 1.887-1.892.
15. Mishiro S, Hoshl Y, Takeda K, Yoshikawa A, Gottanda T, Takahashi K et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 1.400-1.403.
16. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M. Prose P et al. Mixed cryoglubulinemia: clinical aspects and long term follow-uo of 40 patients. Am J Med 1980; 69: 287-308.
17. Esteban JI, López Talavera JC, Genesca J, Madoz P, Viladomiu L, Muñiz E et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443-449.
18. Alter MJ, Margolls HS, Krawczynski K, Judson FN, Mares A, Alexander WJ et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1.899-1.905.
19. Brillanti S, Foll M, Galani S, Masci C, Miglioli M, Barbara L. Persistent hepatitis C viremia without liver disease. Lancet 1993; 341-464-465.
20. Arribas JR, Barbado FJ, Zapico R, Sendino A, González I, Vázquez JJ. Association between hepatitis C virus and myxed cryoglobulinemia. Rev Infect Dis 1991; 213: 770-771.
21. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1.606-1.610.
22. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1.490-1.495.
23. Mislani R, Bellavista P, Fenill D, Borrell G, Marchesi D, Massazza M et al. Hepatitis virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577.
24. Galli M. Viruses and cryoglobulinemia. Clin Exp Rheumatol 1995; 12 (Supl): 63-70.
25. García Monforte A, Rodríguez Molina JJ, Rivera Redondo J. Crioglobulina mixta en la infección por el virus de la hepatitis C. Análisis de factores predisponentes. Rev Esp Reumatol 1995; 23: 210.
26. Rivera J, De Diego A, Trinchel M, García Monforte A, Fybromyalgia associated hepatitis C virus infection. Br J Rheumatol 1997; 36: 981-985.
27. Johnson RJ, Willson R, Yamabe H, Couser W, Alpers CE, Wener MH et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994; 46: 1.255-1.263.
28. Yamabe H, Fukushi K, Oshawa H, Miyata M, Inuma H, Sasaki T et al. Hepatitis C virus Infection may be an important cause of mernbranoproliferative glomerulonephritis in Japan. J Am Soc Neprhol 1993; 4: 291.
29. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470.
30. Dadoud MS, Gibson LE, Daoud S, El-Azahary RA. Chronic hepatitis C and skin diseases: A review. Mayo Clin Proc 1995; 70: 559-564.
31. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J et al. Is hepatitis C virus infection trigger of porphyna cutanea tarda? Lancet 1993; 341: 788-789.
32. De Castro M, Sánchez J, Herrera JF, Chaves A, Durán R, García-Buey L el al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17: 551-557.
33. Rebora A, Rongioletti F. Lichen planus and chronic active hepatitis: a retrospective survey. Acta Derm Venereol 1984; 64: 52-56.
34. Revenga Arranz F, De Argila Fernández-Durán D, Rivera Diaz R, Iglesias Diez L. Liquen plano e infección por el virus de la hepatitis C. Estudio de seis casos. Rev Clin Esp 1995; 195: 550-552.
35. Pawlowsky JM, Ben Yahia M, André C, Voisin MC, Intrator L, Roudot-Zoraval F et al. Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology 1994; 19: 841-848.
36. Romero M, De Diego A, Rivera J, García Monforte A, García Durán F, Piqueras B et al. Manifestaciones reumáticas y autoinmunes en pacientes con infección crónica por el virus de la hepatitis C. Rev Esp Med Digest 1997; 89: 591-594.
37. Cruz L, Gutiérrez C, López I, Descarrega R, Juncosa S, Olivé A et al. Análisis de la derivación de pacientes a un servicio hospitalario de reumatologia. Rev Esp Reumatol 1995; 22: 311-316.
38. Sawada T, Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Reum 1991; 34: 1.620-1.621.
39. Rivera J. García Monforte A, Hepatitis C and Hepatitis B virus infection in rheumatoid arthritis. Arthritis Rheum 1994; 37 (Supl): 245.
40. Vaz Patto J, Peixe P, Parente M, Madeira H, Micaelo M, Teixeira A et al. Treating patients with rheumatoid arthritis and hepatitis C: a major problem. Arthritis Rheum 1996; 39 (Supl): 147.
41. Lovy M, Starkebaum G, Uberol S, Hepatitis C infection with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979-983.
42. Haddad J, Derry P, Munz-Gothell C, Ambrosini JC, Trinchet JC, Pateron D el al. Lymphocytic syaladenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
43. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39: 1.166-1.171.
44. King PD, McMurray RW, Becherer PR, Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994; 89: 1.047-1.050.
45. Luppi M, Ferrari MG, Bonacorsi G, Longo G, Narni F, Barozzi P et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-355.
46. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4.296-4.301.
47. Ferri C, La Civita L, Caracciolo F, Zigneno AL. Non-Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA 1994; 272: 355-356.
48. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Hematol 1995; 90: 548-552.
49. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Cesell S, Mazzi G et al. Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood 1994; 84: 3.047-3.053.
50. Rivera J, Pérez I, Rodriguez JJ, García Morforte A. Non-Hodgkin's lymphomas in patients with mixed cryoglobulinemia. Arthritis Rheum 1996; 39 (Supl): 200.
51. Davies GL, Balart LA, Schliff ER, Bodenheimer HC, Perrillo RP, Carey W et al. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1,501-1.506.
52. Bisceglie AM, Martin P, Kassianldes C, Lisker-Melman M, Murray L, Waggoner J et al. Recombinant Interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1.506-1.510.
53. Mislani R, Bellavista P, Fenill D, Vicari O, Marchesi D, Sironi PL et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756.
54. Quesada J, Talpaz M, Ríos A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986; 4: 234-243.
55. Conlon KC, Urba WJ, Smith JW, Stels RG, Longo DL, Clark JW. Exacerbations of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990; 65: 2.237-2.242.
56. Rönnblom LE, Alm GV, Öberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178-183.
57. Wandl UB, Nagel-Hiemke M, May D, Kreuzfeder E, Kloke O, Kranzhoff M et al. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol 1992; 65: 70-74.
58. Chazerain P, Meyer O, Ribard P, Bandt M, Mechelany C, Marcellin P et al. Three cases of polyarthritis during recombinant alpha-interferon therapy. Rev Rheum Mal Osteoart 1992; 59: 303-309.